ES307300A1 - Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos. - Google Patents

Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.

Info

Publication number
ES307300A1
ES307300A1 ES0307300A ES307300A ES307300A1 ES 307300 A1 ES307300 A1 ES 307300A1 ES 0307300 A ES0307300 A ES 0307300A ES 307300 A ES307300 A ES 307300A ES 307300 A1 ES307300 A1 ES 307300A1
Authority
ES
Spain
Prior art keywords
radical
formula
translation
preparation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0307300A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES307300A1 publication Critical patent/ES307300A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Discharge Lamp (AREA)
ES0307300A 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos. Expired ES307300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
ES307300A1 true ES307300A1 (es) 1965-05-01

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Country Status (12)

Country Link
AT (4) AT249277B (enrdf_load_stackoverflow)
BE (2) BE657406A (enrdf_load_stackoverflow)
CH (7) CH448118A (enrdf_load_stackoverflow)
DE (2) DE1445853A1 (enrdf_load_stackoverflow)
DK (4) DK108496C (enrdf_load_stackoverflow)
ES (4) ES307300A1 (enrdf_load_stackoverflow)
FR (2) FR4346M (enrdf_load_stackoverflow)
GB (2) GB1092394A (enrdf_load_stackoverflow)
IL (2) IL22643A (enrdf_load_stackoverflow)
NL (3) NL6414820A (enrdf_load_stackoverflow)
NO (2) NO119273B (enrdf_load_stackoverflow)
SE (2) SE305657B (enrdf_load_stackoverflow)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
MXPA04011327A (es) 2002-05-17 2005-08-15 Jenken Biosciences Inc Opioides y compuestos similares a opioides y usos de los mismos.
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP5486928B2 (ja) 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター
WO2009017671A1 (en) 2007-07-26 2009-02-05 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2704628C (en) 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
US20110028445A1 (en) * 2008-02-12 2011-02-03 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2715290A1 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001151A1 (es) 2008-05-13 2010-08-13 Boehringer Ingelheim Int Compuestos derivados de acidos carbociclicos aliciclicos de benzomorfanos, procedimiento de preparacion, composicion farmaceutica, utiles para tratar enfermedades influenciadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa, como trastornos metabolicos.
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
EP2324018B1 (en) 2008-07-25 2013-09-04 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
TW201022266A (en) 2008-10-23 2010-06-16 Boehringer Ingelheim Int Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2010139673A1 (en) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
PH12013500808A1 (en) 2010-11-02 2015-10-07 Boehringer Ingelheim Int Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Also Published As

Publication number Publication date
FR4345M (enrdf_load_stackoverflow) 1966-08-16
CH449643A (de) 1968-01-15
DE1445854A1 (de) 1968-12-05
NL6414820A (enrdf_load_stackoverflow) 1965-06-21
CH449642A (de) 1968-01-15
ES307302A1 (es) 1965-05-16
ES307299A1 (es) 1965-05-16
DK106552C (da) 1967-02-20
GB1092394A (en) 1967-11-22
DK108495C (da) 1967-12-27
DE1445853A1 (de) 1968-12-05
AT253687B (de) 1967-04-25
CH449640A (de) 1968-01-15
CH449639A (de) 1968-01-15
BE657405A (enrdf_load_stackoverflow) 1965-06-21
BE657406A (enrdf_load_stackoverflow) 1965-06-21
NL127995C (enrdf_load_stackoverflow)
AT249276B (de) 1966-09-12
AT249277B (de) 1966-09-12
DK108496C (da) 1967-12-27
SE305657B (enrdf_load_stackoverflow) 1968-11-04
CH449641A (de) 1968-01-15
AT261126B (de) 1968-04-10
NO119273B (enrdf_load_stackoverflow) 1970-04-27
ES307301A1 (es) 1965-05-16
DK108497C (da) 1967-12-27
IL22642A (en) 1968-07-25
IL22643A (en) 1968-07-25
SE322779B (enrdf_load_stackoverflow) 1970-04-20
NO119274B (enrdf_load_stackoverflow) 1970-04-27
FR4346M (enrdf_load_stackoverflow) 1966-08-16
CH446371A (de) 1967-11-15
NL6414821A (enrdf_load_stackoverflow) 1965-06-21
CH448118A (de) 1967-12-15
GB1077711A (en) 1967-08-02

Similar Documents

Publication Publication Date Title
ES307300A1 (es) Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES330368A1 (es) Procedimiento para preparar derivados n-alcohilamino-alcohilicos de espirotetralinosuccinimidas y sus sales.
ES269967A1 (es) Un procedimiento para la preparaciën de pirazolonas sustituidas
ES326803A1 (es) Procedimiento para preparar agentes antiparasitarios.
ES440030A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES432566A1 (es) Procedimiento de preparacion de derivados yodados del ben- ceno.
GB1014918A (en) 3-(3-hydroxyphenyl)-1-phenacyl-piperidine compounds and their preparation
ES296634A1 (es) Procedimiento para la producción de nuevos compuestos heterocíclicos
ES274327A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES421093A1 (es) Procedimiento para la preparacion de nuevas 6-azabenzo-1,5-diazepinas.
ES312278A1 (es) Procedimiento para la produccion de amino-etilicos
ES301710A1 (es) Procedimiento para la preparación de nuevas 1,2-diaril-4-alquil-3,5-dioxo-pirazolidinas
ES321808A1 (es) Procedimiento para la sintesis de nuevos derivados de piperidina.
ES305738A1 (es) Procedimiento para la preparacion de nuevos 5-fenil-6,7-benzomorfanos sustituidos.
ES292760A2 (es) Procedimiento de obtención de derivados de 4-aza-tia-xanteno
ES393340A1 (es) Procedimiento para la preparacion de derivados de bornanami-na.
ES316075A1 (es) Procedimiento para la produccion de derivados del tropano.
ES324844A1 (es) Material diazotipia.
ES303517A1 (es) Procedimiento para la producción de compuestos diazaspiro
ES316622A1 (es) Procedimiento para la preparacion de derivados de acetofenona.
ES297247A1 (es) Procedimiento para la preparación de nuevos derivados del ácido 6-amino-penicilánico
ES302395A1 (es) Procedimiento para la preparacion de nuevos derivados de 1, 2,3,6-tetrahidro-piridina.
ES277094A1 (es) Procedimiento de producción de nuevos derivados del tiaxanteno
ES302770A1 (es) Procedimiento para la producción de compuestos heterocíclicos
ES382147A1 (es) Un procedimiento para preparar compuestos de morfolina n- sustituidos.